A Systematic Formulation Approach For The Development Of Olaparib-Loaded Nanostructured Lipid Carriers
International Journal of Drug Delivery Technology · 11.07.2026 · 16 (63s)
DOI: 10.25258/ijddt.16.63s.135 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.07.2026. Verfasst von Gurav N H und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Olaparib (OLP), a potent poly(ADP-ribose) polymerase (PARP) inhibitor, exhibits poor aqueous solubility and limited bioavailability, restricting its therapeutic potential. The present study aimed to systematically develop and optimize olaparib-loaded nanostructured lipid carriers (NLCs) using a rational formulation strategy based on drug–lipid miscibility and required hydrophilic–lipophilic balance (rHLB) principles. OLP-loaded NLCs were prepared by the microemulsion–probe sonication method and optimized using a three-factor, three-level Box– Behnken design. Lauric acid and Capmul MCM were selected as the solid and liquid lipids, respectively, through comprehensive solubility, miscibility, and compatibility studies, while the surfactant system was optimized using rHLB-guided formulation design. The formulations were characterized for particle size, polydispersity index (PDI), entrapment efficiency (%EE), zeta potential, drug loading, in vitro drug release, morphology, and anticancer activity. The optimized formulation (F9) exhibited a particle size of 63.7 nm, PDI of 0.50, entrapment efficiency of 99.84%, zeta potential of −34 mV, and drug loading of 11.48%. XRD and FTIR studies confirmed amorphous drug incorporation and compatibility between OLP and excipients. The formulation provided sustained drug release, achieving approximately 90% release within 12 h through a non-Fickian transport mechanism. TEM analysis revealed well-dispersed spherical nanoparticles. In vitro cytotoxicity studies against HeLa cells demonstrated significantly enhanced anticancer activity of OLP-loaded NLCs compared with the conventional formulation. The systematic formulation strategy successfully produced stable, highly efficient OLP-loaded NLCs with superior drug entrapment, controlled release, and enhanced anticancer efficacy, highlighting their potential as an advanced lipidbased delivery platform for cancer therapy.
Zitieren
APA
H, G. N., & J, S. A. (2026). A Systematic Formulation Approach For The Development Of Olaparib-Loaded Nanostructured Lipid Carriers. International Journal of Drug Delivery Technology, 16(63s). https://doi.org/10.25258/ijddt.16.63s.135
Vancouver
H GN, J SA. A Systematic Formulation Approach For The Development Of Olaparib-Loaded Nanostructured Lipid Carriers. International Journal of Drug Delivery Technology. 2026;16(63s). doi:10.25258/ijddt.16.63s.135
BibTeX
@article{H2026,
author = {H, Gurav N and J, Shinde A},
title = {A Systematic Formulation Approach For The Development Of Olaparib-Loaded Nanostructured Lipid Carriers},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {63s},
doi = {10.25258/ijddt.16.63s.135}
}
EUVIMED